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ABSTRACT
Isolation of proteins that specifically interact with a
given RNA or RNA regulation element is essential for
studiesonthemolecularmechanismsofgeneexpres-
sion. Here, anovel method for direct isolation of such
interacting proteins is described. It uses an affinity
medium that consists of an interacting RNA with an
artificiallyadded‘tail’,whichisannealedtooneendof
aDNA‘arm’,theotherendofwhichisfixedcovalently
on the surface of aminosilanized glass powder. Thus
the RNA itself is fully suspending, facilitating its
interactions withproteinsinitsnaturalconformation.
The proteins bound on the interacting RNA are eluted
and subjected to SDS–PAGE, and the Coomassie-
stained protein bands are cut and subjected to
massspectrometry(MS)analysis.Usingthis method,
threeproteinsspecificallyinteractingwiththeC/EBPb
30-untranslated region (30-UTR) RNA were isolated
andidentified.Thismethod issimpleandconvenient,
and the DNA-glass powder medium can be used
repeatedly.
INTRODUCTION
RNA–protein interactions underlie the most important intra-
cellular biological processes, such as all the steps of gene
expression and its regulation (1) and cellular resistance to
viral infection (2). Therefore, studies on RNA–protein inter-
actions are essential for understanding the mechanisms of
various lifeactivitieswithinthecell.Forthispurpose,isolation
and characterization of the proteins speciﬁcally interacting
with various RNAs are the ﬁrst step of most of these studies.
The methods for isolation of RNA-interacting proteins and/
or their genes or cDNAs are well documented. Screening of a
cDNA expression library with a labeled RNA probe is a com-
mon and effective method (3). Besides, many others speciﬁc
for certain protein factors that interact with RNA in their
functions are available (4–8). A very valuable in vivo method
is the yeast three-hybrid system (9). It is unique in that it has
created an intracellular mechanism for the interaction of spe-
ciﬁc proteinswith their targetRNAs,leading toexpressionofa
reporter gene, which changes the phenotype of the yeast cell
that harbors the cDNA of the protein. These methods are
all useful and meet speciﬁc requirements and conditions of
various studies.
The achievements of the Human Genome Project, and the
advent of the protein mass spectrometry (MS) analysis and
microsequencing (10) have provided new strong tools for
research workers to ﬁnd speciﬁc RNA-interacting proteins.
As little as nanomole, or even less, amounts of protein samples
can be analyzed using MS; therefore, the speciﬁc RNA-
interacting proteins can be identiﬁed successfully, provided
that they can be obtained in these amounts.
Here, a simple and effective method is described for the
direct isolation of proteins that speciﬁcally interact with RNA.
The principle of this method is to isolate RNA-interacting
proteins by using an afﬁnity medium, i.e. a protein-
interacting RNA with its additional ‘tail’ annealed to an end
ofa DNA ‘arm’,whichisimmobilized through itsotherend on
a glass base, and then to separate the bound proteins by SDS–
PAGE. The protein bands in stained gels are subjected to MS
analysis. The 30-untranslated region (30-UTR) of the mRNA
of C/EBPb, a transcription factor currently under our studies,
is used as an example.
MATERIALS AND METHODS
Cell line and extraction of cellular proteins
The SMMC7721 human hepatocarcinoma cell line (11) was
provided by the Cell Bank of the Chinese Academy of
Sciences (Shanghai) and kept in RPMI1640 medium with
10% newborn calf serum (top grade, Si Ji Qing Biotechno-
logical Materials Co. Hangzhou, China, or an equivalent from
Invitrogen) and antibiotics supplemented. The cytoplasmic
proteins (C-fraction, or mixed C- and E-fractions) were
extracted according to literature (12).
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The recombinant plasmid pSP64/0.28, which harbors the
cDNA of the C/EBPb 30-UTR mRNA (0.28 kb fragment,
with the poly A sequence deleted), was constructed by our
group (13). It was digested with PvuII before in vitro tran-
scription with the RiboMax large scale RNA production kit
(Promega) according to the manufacturer’s instructions.
Affinity medium preparation
Preparation of aminosilanized glass powder. Common glass
powder (50–100 mesh, made in Shanghai, China) was cleaned
thoroughly, dried, and allowed to react with a 1:1 (v/v) solu-
tion of 3-aminopropyltriethoxysilane (Sigma) in acetone at
room temperature for 30 min. Then the glass powder was
washed thoroughly with acetone and dried at 50 C.
Activation of DNA ‘arms’. Plasmid pSP65 (Promega) was cut
to its linear form with EcoRI. The linear plasmid (1 mg),
dissolved in 100 ml of 0.1 M MES (pH 6) and 0.5 M NaCl,
was added into a tube containing 0.4 mg of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) (Sigma) and 1 mg
of N-hydroxysuccinimide (Shanghai, China). The mixture was
incubated at room temperature for 30 min. The reaction was
stopped by the addition of 2 ml of 2-mercaptoethanol, and the
DNA was precipitated, washed and dissolved in 0.1 M MES
(pH 6) and 0.5 M NaCl.
Mounting DNA ‘arms’ on glass powder surface. The solution
of activated pSP65 plasmid DNA was mixed with 0.5–1 g of
aminosilanized glass powder and allowed to react for 2 h
at room temperature, with shaking. The glass powder was
washed thoroughly with TE buffer. The mounting efﬁciency
was estimated by the mixing of about 10
5 c.p.m. of the
32P-labeled pSP65 with the activated pSP65 and measuring
the immobilized radioactivity. Before using, the DNA-glass
powder was treated with HindIII (100 U/g) for 2–4 h, and then
washed thoroughly with TE buffer.
Annealing RNA on the DNA ‘arms’. The in vitro transcribed
C/EBPb 30-UTR RNA (0.5 mg) was dissolved in the annealing
buffer [90 mM NaCl, 2 mM EDTA, 10 mM HEPES (pH 7.8)]
and mixed with the HindIII-treated DNA-glass powder. The
mixture was incubated at 70 C for 10 min, cooled slowly
(2–3 C/min) to 37 C, incubated again at 37 C for 2 h with
shaking, and then cooled slowly to 4 C. The RNA–DNA-glass
powder was washed thrice with the annealing buffer at 0–4 C,
and stored at 4 C or frozen. The annealing efﬁciency was
estimated by including about 10
5 c.p.m. of
32P-labeled
C/EBPb 30-UTR RNA in the mixture, and counted the radio-
activity remained on the glass powder.
Affinity capture of specific C/EBPb 30-UTR
RNA–interacting proteins
The cytoplasmic fraction(s) of the SMMC7721 human hepa-
tocarcinoma cell extract (1 ml, about 10
7 cells) was mixed at
0 C with 0.25 ml of cooled 5· binding buffer [200 mM KCl,
15 mM MgCl2, 50 mM HEPES (pH 7.8), 5 mM DTT, 15% v/v
glycerol, 50 mg/ml heparin sodium and 200 mg/ml yeast
tRNA], and added to 0.5 g of 0 C ice-cold RNA–DNA-
glass powder medium. The tube with the mixture was ﬁxed
to the rotation axle of a Pynus 70YN-2CT120G micromotor
with speed regulator (Pynus Micromotor Factory, Shanghai),
and rotated at 1 r.p.m. at 0–4 C for 4 h or overnight. Subse-
quently, the RNA–DNA-glass powder was washed at 0–4 C
with 1· binding buffer 5 times, 1 ml each time, and then
with annealing buffer thrice, 1 ml each time. Finally, the
RNA–DNA-glass powder was mixed with 1· protein loading
buffer, heated at 80 C for 5 min, and the eluted proteins were
electrophoresed on an 8% SDS–polyacrylamide gel. The
Coomassie- stained protein bands were cut and analysed
by MS.
Re-use of the DNA-glass powder
After elution, the afﬁnity medium was heated at 80 C for
15 min in a large volume (3–4 ml) of TE with intermittent
shaking, and then washed several times with TE at room
temperature. The washed DNA-glass powder can be re-used
for annealing with newly prepared RNA, at least for two
additional uses.
Binding and UV-crosslinking of specific interacting
proteins with C/EBPb 30-UTR RNA
The reaction mixtures contained 10 ml of cytoplasmic extract,
4 mlo f5 · binding buffer, 5 mlo fH 2O and 1 mlo f
32P-labeled
C/EBPb 30-UTR RNA probe. The mixtures were incubated at
room temperature (20–26 C) for 10 min, followed by UV
irradiation with two 15 W UV tubes at 0 C for 30 min. The
horizontal distance between UV tubes was 5 cm. The sample
tubes (0.5 ml Eppendorf tubes), laid on a sheet of Saran Wrap
covered over an ice-cold water surface, were mounted just
beneath the UV tubes at a distance of about 10 cm. After
UV treatment, each sample was digested with 1 mlo f
10 mg/ml RNase A (Promega) at 37 C for 20 min, and then
separated by SDS–PAGE as before. The gels were ﬁxed, dried
and autoradiographed.
Fortargetremovalexperiments,10mlofcytoplasmicextract
were incubated with 1 ml of appropriate antibodies (kindly
provided by Rong Zeng and Kan Liao; Santa Cruz) at 4 C
for 2 h, and then incubated with 2 ml of protein A-Sepharose
(kindly provided by Xue-Jun Zhang and Mu-Jun Zhao) for 2 h.
The mixtures were centrifuged and the supernatants were used
for binding and UV-crosslinking experiments as above. The
mouse anti-IgG antibody was used as a control.
RESULTS
Principle of the method
The principle of this method is illustrated in Figure 1. The
interacting RNA is transcribed in vitro from the coding strand
(+) of the recombinant pSP64 plasmid, which has been cut to
linear form by the restriction enzyme PvuII; thus transcript
contains a segment of RNA that is complementary to the
vector sequence between the polycloning site and PvuII site,
i.e. a ‘tail’, at the 30 end of the RNA. On the other hand, the
plasmid pSP65, which shares the plasmid sequence with
pSP64 except for the polycloning sites in reverse orientation,
is cut with EcoRI. The linear pSP65 has phosphorylated
50-termini, which can be activated by the water-soluble carbo-
diimide (EDC) and then linked covalently to an amino group
on the aminosilanized glass. After HindIII treatment and
heating, the strand of pSP65 identical to the (+) strand
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sequence complementary to the ‘tail’ of the interacting RNA
remains linked to the glass, with the complementary sequence
at the end that suspends in the microenvironment. Therefore,
the interacting RNA is easy to anneal to that end. This anneal-
ing does not affect to the RNA itself, which at
least theoretically should keep its natural conformation and
bind its speciﬁc interacting proteins normally.
The amount of pSP65 DNA linked covalently on the amino
glasswas estimatedtobe2mg/gglass powder ormore,andthe
C/EBPb 30-UTR RNA which can be bound on the DNA-glass
powder was about 50–100 mg/g glass powder.
Direct isolation and identification of C/EBPb
30-UTR RNA-specific interacting proteins
by using the RNA–DNA-glass medium
Previously, we found that the C/EBPb 30-UTR RNA specif-
ically interacts with several cytoplasmic proteins (Figure 2).
The method described above was used to isolate and identify
them. Accordingly, a C/EBPb 30-UTR RNA afﬁnity medium
was used for binding the speciﬁc cellular interacting proteins,
with the DNA-medium without RNA as control. By using
Coomassie blue BB250 staining, three apparent protein bands
were detected reproducibly, whereas no band was found in
corresponding positions in the lane to eluate from the control
medium (Figure 3). These three bands were cut and sent to
the National University of Singapore for MALDI-TOF-MS
analysis. Results indicated that these proteins were vimentin,
cytokeratin 8 and cytokeratin 18, respectively.
To conﬁrm these results we performed a gel shift assay.
However, when the antibodies to vimentin, cytokeratins 8 and
18 were allowed to interact with the cytoplasmic extract, and
the binding was performed, almost all the radioactivity
Figure 1. Construction of the affinity medium. The C/EBPb 30-UTR RNA is transcribed from the coding strand of pSP64/0.28 plasmid cut with PvuII, so that a
segment of the vector sequence is also transcribed forming a ‘tail’ at the 30 end of the RNA. The pSP65 plasmid was cut with EcoRI, so that, after EDC activation,
linking to amino-glass surface, cutting with HindIII and heating, the minus strand of it remains linked on the glass with the sequence complementary to the ‘tail’
suspending. Therefore, the RNA is easily annealed to the DNA strand through its ‘tail’, leaving the RNA itself freely suspending, facilitating its interactions with
proteins. The sequence complementary to ‘tail’ is shown in black.
Figure 2. Binding and UV-croslinking of cytoplasmic proteins to the
32P-labeled C/EBPb 30-UTR RNA probe in the absence and presence of a
specific RNA competitor (C/EBPb 30-UTR RNA) or a non-specific RNA
competitor (tubulin RNA). Numbers indicate approximate molar ratios
between competitors and the probe. PhosphorImager image is shown.
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Considering that these proteins might be interacting with
each other (14), efforts were made to do the immune reactions
under denaturing conditions, but still failed (data not shown).
Therefore, a ‘target removal’ strategy was used in the identi-
ﬁcation, i.e. to remove the proteins to be checked from the
cellular extract before binding with radiolabeled RNA. Should
this strategy work, some bands on the autoradiograph, repre-
senting the protein bound by a certain antibody,wouldbecome
weaker. The result is shown in Figure 4. Although, this is not
clear-cut, it is discernible that several bands are weaker com-
pared with the control as well as with other bands, showing the
likely positions of the three proteins. Therefore, these three
proteins existed in the pool crosslinked to C/EBPb 30-UTR
RNA. The observation that one antibody often caused weak-
ening of more than one band, was perhaps due to the inter-
actions between those proteins.
DISCUSSION
This method was designed to meet our needs, that is, to inves-
tigate the proteins speciﬁcally interacting with C/EBPb 30-
UTR RNA. Our group has found that this 30-UTR suppressed
the malignant phenotype of the SMMC7721 human hepato-
carcinoma cells (15), indicating that the interactions between
this 30-UTR and trans-acting proteins should play some role in
the cellular phenotypic reversion. Efforts made to isolate those
proteins led to develop this direct afﬁnity method.
By using this method, three proteins interacting with
C/EBPb 30-UTR RNA were identiﬁed. The bands of the pro-
teins captured by the RNA–DNA-glass powder were very
reproducible, and their amounts were enough for MS analysis.
Moreover, the glass powder sediments very quickly, the
washing could be performed without centrifugation.
Thekeypointforsuccessofthismethod isthatthe capturing
should be done at low temperature (0–4 C). At such tempera-
tures, the amounts of bound proteins were not signiﬁcantly
different with incubations of 4 h or overnight, a sign that the
RNA was not degraded markedly, even in the absence of
added RNase inhibitor. At higher temperatures (e.g. 25 C),
RNase inhibitors (e.g. RNasin) must be added to protect RNA
integrity. The ProtectRNA  RNase inhibitor (Sigma), how-
ever, should be used with care, because it may prevent the
binding of proteins to RNA.
The main disadvantage of this method is that less abundant
or weakly interacting proteins may be more difﬁcult to be
captured. Furthermore, for different proteins and RNAs, the
composition of the binding buffer may need modiﬁcation.
In our work, three cytoskeleton proteins were found to
interact with the C/EBPb 30-UTR RNA. Despite the cytoskele-
tal proteins being components of the cellular architecture,
recent data indicate that the cytoskeleton proteins, especially
the intermediate ﬁlament components such as cytokeratins, are
dynamic and motile within the cell (16). Therefore, we are
inclined to think that they may also play the role of trans-
acting factors, and interact with their target RNAs to perform
some functions yet to be determined.
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Figure 3. Analysis by PAGE of the proteins bound on the C/EBPb 30-UTR
RNA–DNA-glass powder medium. Cytoplasmic extract before reaction with
the affinity medium (lanes 1 and 6). Cytoplasmic extract that was not bound
to the C/EBPb 30-UTR RNA–DNA-glass powder medium (lane 2). Eluate
from the C/EBPb 30-UTR RNA–DNA-glass powder medium (lane 3). Eluate
from the control DNA-glass powder medium (without RNA) (lane 4). Cyto-
plasmic extract that was not bound to the control DNA-glass powder medium
(lane 5). Arrows indicate bands of vimentin (VIM), cytokeratin 8 (CK8)
and cytokeratin 18 (CK18), respectively, in lanes 3. (a), Staining was with
Coomassie brilliant blue R-250. (b), Silver staining of the gel that was stained
with Coomassie brilliant blue R-250.
Figure 4. ‘Target removal’ experiment to identify proteins that specifically
interact with C/EBPb 30-UTR RNA. Various antibodies were used to remove
their respective target proteins from the cytoplasmic extract before binding
andUV-crosslinkingwiththeC/EBPb30-UTRRNAprobe.Thecontrolwasan
anti-IgG antibody. Vim, vimentin; CK8, cytokeratin 8; CK18, cytokeratin 18.
PhosphorImager image with the contrast enhanced.
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